LPAM
NVO

Lodestar Private Asset Management’s Novo Nordisk NVO Stock Holding History

Lodestar Private Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,147
Closed -$256K – 216
2024
Q3 		$256K Hold
2,147
– – 0.03% 195
2024
Q2 		$306K Hold
2,147
– – 0.04% 170
2024
Q1 		$276K Buy
2,147
+15
+0.7% +$1.79K 0.04% 183
2023
Q4 		$221K Buy
+2,132
New +$211K 0.03% 192

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lodestar Private Asset Management's NVO Position: Q4 2024 in Review

Lodestar Private Asset Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,147 shares — an estimated $256K sold.

Lodestar Private Asset Management first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $306K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Lodestar Private Asset Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Lodestar Private Asset Management sold 2,147 Novo Nordisk shares in Q4 2024, an estimated $256K.
  • Lodestar Private Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • Lodestar Private Asset Management's Novo Nordisk position peaked at $306K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Lodestar Private Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.